市場調査レポート

商品コード

1619111

心血管デバイス市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Cardiovascular Devices Market Size, Share, Growth Analysis, By Product (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia), By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 798,657円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 934,278円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,069,899円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=150.69円

全表示
概要
目次

概要

サンプル依頼リストに入れる

心血管デバイスの世界市場規模は、2022年に449億米ドルと評価され、2023年の491億米ドルから2031年には949億米ドルに成長し、予測期間中（2024～2031年）のCAGRは8.5％で成長する見通しです。

世界の心血管系機器市場は、慢性心血管系疾患の罹患率の上昇に牽引され、力強い成長を遂げています。ハーバードのT.H. Chan School of Public Healthの研究によると、インドのマハラシュトラ州で心停止が43%増加したことが指摘されており、これは冠動脈ステントのコスト低下によるものと考えられています。冠動脈バイパス療法を筆頭に、心臓に不可欠な医薬品価格の下落は、特にインドのような新興経済国での市場拡大をさらに後押ししています。主な成長促進要因としては、急速な技術進歩、心血管系疾患の世界の負担増、侵襲性の低い治療法へのシフトなどが挙げられます。さらに、心臓機器製造の技術革新により適応症が拡大し、患者管理が改善されたことで、ペースメーカーのような機器が世界的に心臓病の効果的な診断と治療に重要な役割を果たしていることが明らかになっています。

市場概要
診断および監視デバイス
- 心電図
- 埋め込み型心臓モニター
- ホルターモニター
- モバイル心臓テレメトリー
- MRI
- 心臓血管超音波検査
- 2D
- 3D/4D
- ドップラー
- 心臓診断カテーテル
- PETスキャナー
外科用機器
- 心臓再同期療法（CRT）
- CRT除細動器
- CRTペースメーカー
- 植込み型除細動器（ICD）
- 単室型ICD
- デュアルチャンバーICD
- ペースメーカー
- 従来型ペースメーカー
- リードレスペースメーカー
- 冠動脈ステント
- カテーテル
- ガイドワイヤー
- カニューレ
- バルブ
- 閉塞装置

心血管デバイス市場規模：用途別およびCAGR（2024～2031年）

市場概要
冠動脈疾患（CAD）
不整脈
心不全
その他

心血管デバイス市場規模：エンドユーザー別およびCAGR（2024～2031年）

市場概要
病院
専門クリニック
その他

心血管デバイス市場規模およびCAGR（2024～2031年）

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021～2023年）

主要企業プロファイル

Abbott Laboratories
Boston Scientific Corporation
Medtronic, Inc.
Johnson & Johnson
Terumo Corporation
Edwards Lifesciences Corporation
Biotronik SE & Co. KG
LivaNova PLC
Getinge AB
Baxter International Inc.（Hill-Rom Holdings, Inc.）
Koninklijke Philips N.V.
Siemens Healthineers AG
GE Healthcare
Toshiba Corporation
Fujifilm Holdings Corporation
Hitachi, Ltd.
Nihon Kohden Corporation
Collateral Medical Pvt. Ltd.
Schiller AG
B. Braun Melsungen AG

結論と推奨事項

Product Code: SQMIG35E2016

Global Cardiovascular Devices Market size was valued at USD 44.9 billion in 2022 and is poised to grow from USD 49.1 billion in 2023 to USD 94.9 billion by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).

The global cardiovascular device market is experiencing robust growth, driven by the rising incidence of chronic cardiovascular diseases. A study from Harvard's T.H. Chan School of Public Health highlights a 43% surge in cardiac arrests in Maharashtra, India, attributed to the reduced costs of coronary stents. The decline in essential cardiac drug prices, notably coronary artery bypass therapy, is further propelling market expansion, particularly in emerging economies like India. Key growth drivers include rapid technological advancements, a rising global burden of cardiovascular conditions, and a shift towards less invasive treatment options. Additionally, innovation in cardiac device manufacturing has broadened indications and improved patient management, underscoring the vital role of devices like pacemakers in effectively diagnosing and treating heart diseases globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiovascular Devices Market Segmental Analysis

Global Cardiovascular Devices Market is segmented by product, application, end user and region. Based on product, the market is segmented into Diagnostic & Monitoring Devices (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Cardiovascular Ultrasound (2D, 3D/4D, Doppler), Cardiac Diagnostic Catheters, PET Scanner), Surgical Devices (Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemaker), Implantable Cardioverter Defibrillators (ICDs) (Single Chamber ICDs, Dual Chamber ICDs), Pacemakers (Conventional Pacemakers, Leadless Pacemakers), Coronary Stents, Catheters, Guidewires, Cannula, Valves, Occlusion Devices). Based on application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is significantly influenced by the escalating incidence of cardiovascular diseases (CVDs), which remain the foremost cause of mortality worldwide. The rising prevalence of sedentary lifestyles, unhealthy diets, and an aging demographic contributes to an increased risk of conditions like congestive heart failure, hypertension, and heart failure. As a result, there is a growing necessity for vital medical devices, including pacemakers, defibrillators, and stents, particularly in both developed and developing regions. Health systems are now focusing on preventive care and early disease detection, while hospitals and clinics adopt advanced technologies to enhance patient outcomes. Furthermore, government initiatives and nonprofit organizations are actively promoting awareness among high-risk populations, further driving the market's growth.

Restraints in the Global Cardiovascular Devices Market

One significant constraint faced by the global cardiovascular devices market is the high cost associated with advanced equipment. This challenge is particularly pronounced in developing regions where the affordability of advanced devices, such as implantable cardioverter defibrillators (ICDs) and sophisticated imaging technologies, proves to be a substantial hurdle. The hefty price tags attached to these devices can deter healthcare providers and patients alike, limiting their availability and accessibility. Furthermore, inadequate insurance coverage and reimbursement options in certain areas exacerbate this issue, leaving patients without access to potentially life-saving technologies, ultimately hindering the growth and adoption of cardiovascular interventions.

Market Trends of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is experiencing a significant shift towards expanding home health solutions, driven by the increasing demand for self-management tools and remote patient monitoring technologies. Wearable ECG devices, blood pressure monitors, and other innovative remote monitoring solutions enable patients to capture real-time health data, empowering them to manage chronic conditions like heart failure more effectively from the comfort of their homes. This trend not only improves patient convenience and engagement but also reduces healthcare costs and enhances the focus on preventive care. As patients seek greater autonomy in managing their health, the market is poised for sustained growth and innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
PESTEL Analysis
Macro-Economic Indicators
Market Attractiveness Index

Global Cardiovascular Devices Market Size by Product & CAGR (2024-2031)

Market Overview
Diagnostic & Monitoring Devices
- ECG
- Implantable Cardiac Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
- MRI
- Cardiovascular Ultrasound
- 2D
- 3D/4D
- Doppler
- Cardiac Diagnostic Catheters
- PET Scanner
Surgical Devices
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillator
- CRT-Pacemaker
- Implantable Cardioverter Defibrillators (ICDs)
- Single Chamber ICDs
- Dual Chamber ICDs
- Pacemakers
- Conventional Pacemakers
- Leadless Pacemakers
- Coronary Stents
- Catheters
- Guidewires
- Cannula
- Valves
- Occlusion Devices

Global Cardiovascular Devices Market Size by Application & CAGR (2024-2031)

Market Overview
Coronary Artery Disease (CAD)
Cardiac Arrhythmia
Heart Failure
Others

Global Cardiovascular Devices Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals
Specialty Clinics
Others

Global Cardiovascular Devices Market Size & CAGR (2024-2031)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (Hill-Rom Holdings, Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toshiba Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collateral Medical Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments